Quantcast
5 Undervalued ‘Fat Pitch’ Blue-Chip Dividend Stocks

5 Undervalued ‘Fat Pitch’ Blue-Chip Dividend Stocks

Posted On April 4, 2019 11:40 am
By:

Find out how I’m running my retirement portfolio and why three out of these five stocks is what I’m buying aggressively right now.

Summary

  • For five years, I’ve been an investing analyst and have continued to improve my analysis/knowledge base/approach.
  • That’s helped me improve my retirement portfolio, shifting from higher-risk strategies to more effective and safer ones based on deeply undervalued blue-chips and SWANs.
  • This article highlights my current retirement portfolio strategy, which is how I’m running my fast growing life savings right now.
  • AbbVie, Tanger, Bristol-Myers, CVS Health, and Walgreens are five of my top ultra-value, “fat pitch” blue-chip dividend recommendations right now.
  • But due to my portfolio’s risk management rules, CVS, Walgreens, and Bristol are the only companies I have limits on right now for as long as the yield curve remains positive.

Continue Reading HereĀ 

Photo: “5” by joannapoe is licensed under CC BY-SA

About author

Dividend Sensei
Dividend Sensei

I'm an Army veteran and former energy dividend writer for The Motley Fool. I currently write for both Seeking Alpha, Simply Safe Dividends, and DividendSensei.com My goal is to help all people learn how to harness the awesome power of dividend growth investing to achieve their financial dreams, and enrich their lives. With 22 years of investing experience, I've learned what works and more importantly, what doesn't, when it comes to building long-term wealth and income streams. I'm currently on an epic quest to build a broadly diversified, high-quality, high-yield dividend growth portfolio that: 1. Pays a 5% yield 2. Offers 7% annual dividend growth 3. Pays dividends AT LEAST on a weekly, but preferably, daily basis

Related Articles

Leave a reply

Your email address will not be published. Required fields are marked *